Patents Examined by George R. Evanisko
  • Patent number: 11400298
    Abstract: Techniques are disclosed for using a rate of wireless telemetry of an implantable medical device (IMD) to estimate a remaining longevity of a power source of the IMD. For example, the IMD sets a timer indicative of a remaining power capacity of the power source until a recommended replacement time (RRT) threshold. The IMD determines a power consumption of the IMD due to telemetry and updates, based on the power consumption of the IMD due to telemetry, the timer indicative of the remaining power capacity of the power source. The IMD determines, based on expiration of the timer indicative of the remaining power capacity of the power source, that the power source has reached the RRT threshold. In some examples, the IMD may output, to an external device and for display to a user, an indication that the power source has reached the RRT threshold.
    Type: Grant
    Filed: May 4, 2020
    Date of Patent: August 2, 2022
    Assignee: Medtronic, Inc.
    Inventors: Matthew J. Hoffman, Matthew P. Hanly, Evan S. Johnson, Gary J. Pauly, Jerry D. Reiland, Melani G. Sullivan, Ryan D. Wyszynski, Hyun J. Yoon
  • Patent number: 11395913
    Abstract: A method and a system for measuring a main electrically evoked compound action potential is described. The system may comprise a cochlea implant system which includes an electrode array, and where the electrode array includes at least a stimulator electrode, a first recording electrode and a second recording electrode, and where the first recording electrode is arranged closer to the stimulator electrode than the second recording electrode, a processor electrically in communication with the cochlea implant system.
    Type: Grant
    Filed: December 19, 2019
    Date of Patent: July 26, 2022
    Assignee: Oticon Medical A/S
    Inventors: Behnam Molaee, Manuel Segovia Martinez
  • Patent number: 11389656
    Abstract: An active implantable medical device for neurostimulation therapy is disclosed. The device produces stimulation pulse sequences generated continuously in succession during activity periods separated by intermediate inactivity periods during which no stimulation is issued. An input signal, provided by a physiological sensor, representative of cardiac activity and/or of the patient's hemodynamic status is received by circuitry. The circuitry further provides for dynamic control of the neurostimulation therapy, wherein the length of activity periods is modulated based on the current value level of the control parameter compared to a threshold. The duration of the next period of inactivity is calculated by the circuitry at the end of each activity period to maintain a constant duty cycle ratio between periods of activity and periods of inactivity.
    Type: Grant
    Filed: December 21, 2018
    Date of Patent: July 19, 2022
    Assignees: SORIN CRM SAS, UNIVERSI IÉ DE RENNES 1, INSERM—INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
    Inventors: Jean-Luc Bonnet, Alfredo Hernandez, Guy Carrault, Hector Romero
  • Patent number: 11382551
    Abstract: Systems and methods for recording bipolar electrogram signals by dynamically selecting electrode pairs. For a particular electrode of interest, a reference electrode is identified as the physically closest electrode to the electrode of interest that satisfies at least one selection criterion indicative of an absence of concurrent electrical activation.
    Type: Grant
    Filed: May 5, 2020
    Date of Patent: July 12, 2022
    Assignee: Duke University
    Inventor: Stephen Gaeta
  • Patent number: 11376420
    Abstract: A terminal tool includes a main body, an electrical connector body, and an electrical connector. The main body includes a distal clamping section and a shaft. The shaft includes a window and a first lumen extending through the shaft for receiving a terminal end of an implantable lead. The electrical connector body includes a second lumen and is independently rotatable with respect to the main body. The shaft at least partially extends through the second lumen. The electrical connector is coupled to the electrical connector body and extends at least partially through the window of the shaft.
    Type: Grant
    Filed: January 16, 2020
    Date of Patent: July 5, 2022
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: Andrew L. De Kock, G. Shantanu Reddy, Matthew J. Miller, Kenneth Matrin Stein, Lili Liu
  • Patent number: 11364382
    Abstract: Recovery circuitry for passively recovering charge from capacitances at electrodes in an Implantable Pulse Generator (IPG) is disclosed. The passive recovery circuitry includes passive recovery switches intervening between each electrode node and a common reference voltage, and each switch is in series with a variable resistance that may be selected based on differing use models of the IPG. The passive recovery switches may also be controlled in different modes. For example, in a first mode, the only recovery switches closed after a stimulation pulse are those associated with electrodes used to provide stimulation. In a second mode, all recovery switches are closed after a stimulation pulse, regardless of the electrodes used to provide stimulation. In a third mode, all recovery switches are closed continuously, which can provide protection when the IPG is in certain environments (e.g., MRI), and which can also be used during stimulation therapy itself.
    Type: Grant
    Filed: July 16, 2020
    Date of Patent: June 21, 2022
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Emanuel Feldman, Goran N. Marnfeldt, Jordi Parramon
  • Patent number: 11351370
    Abstract: Systems and methods for treating cognitive dysfunction and/or depression using transcutaneous auricular neurostimulation therapy may include positioning a wearable neurostimulation device about the ear of the patient, connecting the wearable neurostimulation device, to a pulse generator, and delivering a first series of stimulation pulses to at least one first electrode, the first series being configured to increase monoamine neurotransmitter availability, and delivering a second series of stimulation pulses to at least one second electrode, the second series being configured to upregulate opioid receptor agonists.
    Type: Grant
    Filed: March 31, 2021
    Date of Patent: June 7, 2022
    Assignee: Spark Biomedical, Inc.
    Inventors: Alejandro Covalin, Navid Khodaparast, Daniel Powell
  • Patent number: 11331507
    Abstract: Implantable cardioverter device (ICD) systems capable of delivering a multi-vector defibrillation shock, and methods for use therewith, are described herein. Such an ICD system can include a defibrillation charge capacitor, a charge circuit, first, second, and third electrodes, switches, a controller, and first, second and third filters. The defibrillation charge capacitor is coupled between a first voltage rail and a second voltage rail. The first filter is coupled between the first and second electrodes, and the second filter is coupled between the second and third electrodes, so that the first and second filters can shunt EMI signals. The third filter is coupled between the first and third electrodes and configured to provide for electrical symmetry when the first, second, and third electrodes are used to deliver a multi-vector defibrillation shock. Such filters, which can be implemented using capacitors, can be used to make the ICD system MRI compatible.
    Type: Grant
    Filed: October 25, 2019
    Date of Patent: May 17, 2022
    Assignee: Pacesetter, Inc.
    Inventors: Jeffery Crook, Eiji Shirai, Arpitha Ravishankar
  • Patent number: 11324543
    Abstract: Apparatuses, systems and methods are provided for treating pulmonary tissues via delivery of energy, generally characterized by high voltage pulses, to target tissue using a pulmonary tissue modification system (e.g., an energy delivery catheter system). Example pulmonary tissues include, without limitation, the epithelium (the goblet cells, ciliated pseudostratified columnar epithelial cells, and basal cells), lamina propria, submucosa, submucosal glands, basement membrane, smooth muscle, cartilage, nerves, pathogens resident near or within the tissue, or a combination of any of these. The system may be used to treat a variety of pulmonary diseases or disorders such as or associated with COPD (e.g., chronic bronchitis, emphysema), asthma, interstitial pulmonary fibrosis, cystic fibrosis, bronchiectasis, primary ciliary dyskinesia (PCD), acute bronchitis and/or other pulmonary diseases or disorders.
    Type: Grant
    Filed: March 26, 2021
    Date of Patent: May 10, 2022
    Assignee: Galvanize Therapeutics, Inc.
    Inventors: Jonathan Reuben Waldstreicher, William Sanford Krimsky, Denise M. Zarins, Robert J. Beetel, Paul Brian Friedrichs, Kevin James Taylor, Roman Turovskiy, Robert E. Neal, II
  • Patent number: 11324953
    Abstract: A patient control is disclosed that facilitates operation of an implantable medical device.
    Type: Grant
    Filed: October 31, 2019
    Date of Patent: May 10, 2022
    Assignee: Inspire Medical Systems, Inc.
    Inventors: John Rondoni, Blake D. Johnson, Quan Ni
  • Patent number: 11311732
    Abstract: The present invention is generally directed to methods, systems, and computer program products for coordinating musculoskeletal and cardiovascular hemodynamics. In some embodiments, a heart pacing signal causes heart contractions to occur with an essentially constant time relationship with respect to rhythmic musculoskeletal activity. In other embodiments, prompts (e.g., audio, graphical, etc.) are provided to a user to assist them in timing of their rhythmic musculoskeletal activity relative to timing of their cardiovascular cycle. In further embodiments, accurately indicating a heart condition during a cardiac stress test is increased.
    Type: Grant
    Filed: December 18, 2019
    Date of Patent: April 26, 2022
    Assignee: Pulson, Inc.
    Inventors: Jeffery L. Bleich, Paul Mannheimer, Darin Howard Buxbaum
  • Patent number: 11304626
    Abstract: A method to identify feature points associated with the heart valve movement, heart contraction or cardiac hemodynamics is revealed. The mechanocardiography (MCG) is a technology that makes use of vibrational waveforms acquired using at least one gravity sensor attached on one of the four heart valve auscultation sites on the body surface. The data of the electrocardiography (ECG) is recorded simultaneously with the MCG The feature points are identified by comparing P, R and T points of synchronized ECG with the MCG spectrum. By the time sequences and amplitudes of the feature points, the method provides additional clinical information of cardiac cycle abnormalities for diagnosis.
    Type: Grant
    Filed: July 10, 2020
    Date of Patent: April 19, 2022
    Assignee: Chang Gung University
    Inventors: Wen-Yen Lin, Ming-Yih Lee, Po-Cheng Chang, Wen-Zheng Zhou
  • Patent number: 11266831
    Abstract: Cochlear implant systems can include first and second subsystems, each subsystem including an input source, a signal processor, a stimulator, and a cochlear electrode. A single implantable battery and/or communication module can provide power to and communicate with each subsystem, such as via each signal processor. Systems can include separate leads providing separate communication between the implantable battery and/or communication module and each subsystem, or can include a bifurcated lead providing signals to both subsystems simultaneously. The implantable battery and/or communication module can be configured to output addressed signals designating for which subsystem a signal is intended. The implantable battery and/or communication module can be configured to separately update settings associated with each respective subsystem, such as a transfer function associated with each signal processor.
    Type: Grant
    Filed: February 21, 2020
    Date of Patent: March 8, 2022
    Assignee: Envoy Medical Corporation
    Inventors: Paul R. Mazanec, Benjamin R. Whittington, Timothy J. Earnest, Joshua J. Wibben
  • Patent number: 11266834
    Abstract: An electro-acupuncture (EA) system and method for performing EA on a patient are provided. The EA system comprises a wearable neurostimulator device, at least a first pair of electrically-conductive acupuncture needles and a system controller. The wearable neurostimulator device comprises a casing, an EA circuit mechanically coupled to the casing, and an attachment device mechanically coupled to the casing and adapted to removably secure the wearable neurostimulator device to the patient. The first pair of electrically-conductive acupuncture needles is mechanically coupled to the casing and electrically coupled to the EA circuit. The system controller is in communication with the EA circuit of the wearable neurostimulator device via a communication link and controls the EA circuit to cause the EA circuit to output an output voltage selected by the system controller at a frequency selected by the system controller.
    Type: Grant
    Filed: September 27, 2019
    Date of Patent: March 8, 2022
    Assignee: Board of Supervisors of Louisiana State University and Agricultural and Mechanical College
    Inventors: Jin-Woo Choi, Jose Aquiles Parodi Amaya, Ronald Koh
  • Patent number: 11260233
    Abstract: According to some aspects, a cardiac pacemaker for implantation within a subject is provided, the pacemaker including a housing, at least one sensor configured to detect an activity level of the subject, and at least one processor coupled to the sensor configured to detect inactivity of the subject based on output from the at least one sensor, produce a first signal configured to increase the heart rate of the subject to a first heart rate during a first time period, wherein the first heart rate is above a resting heart rate and below 100 beats per minute, and in response to determining that the first time period has elapsed, producing a second signal configured to increase the heart rate of the subject to a second heart rate during a second time period, wherein the second heart rate is between 100 and 140 beats per minute.
    Type: Grant
    Filed: October 6, 2017
    Date of Patent: March 1, 2022
    Assignee: The University of Vermont and State Agricultural College
    Inventor: Markus Meyer
  • Patent number: 11260227
    Abstract: A method of calibrating stimulation threshold levels of a cochlear implant, comprises sending a series of stimulation signals having a predetermined length in time to a selected subset of a plurality of stimulation electrodes of the cochlear implant of a user, wherein for each signal of the series of stimulation signals, the stimulation level is larger compared to the stimulation level of the previous stimulation signal; receiving an electrophysiological signal for each stimulation signal from a measurement electrode attached to the head of the user; calculating a cross-correlation signal for each of the received electrophysiological signals for each stimulation level following the first stimulation signal with respect to the first electrophysiological signal received for the first stimulation signal, determining, whether the respective cross-correlation signal exceeds a predetermined threshold level, wherein the sending of the series of stimulation signals is stopped and the stimulation level is set as the t
    Type: Grant
    Filed: October 16, 2019
    Date of Patent: March 1, 2022
    Assignee: OTICON MEDICAL A/S
    Inventors: Pierre Stahl, Dan Gnansia
  • Patent number: 11260220
    Abstract: Cochlear implant systems can include a signal processor, an implantable battery and/or communication module, and a plurality of conductors coupling the implantable battery and/or communication module and the signal processor. The implantable battery and/or communication module can communicate data and deliver electrical power to the signal processor via the plurality of conductors. The implantable battery and/or communication module can be configured to perform characterization process to determine one or more characteristics of one or more such conductors. Characterization processes can include determining an impedance between two conductors as a function of frequency, determining whether a conductor is intact, and determining an impedance of a given conductor. Some characterization processes include grounding one or more conductors.
    Type: Grant
    Filed: February 21, 2020
    Date of Patent: March 1, 2022
    Assignee: Envoy Medical Corporation
    Inventors: Paul R. Mazanec, Joshua J. Wibben, Timothy J. Earnest
  • Patent number: 11253695
    Abstract: A handheld, therapeutic electrode and connector that are compatible with high voltages from a pulse generator are disclosed. The electrode includes therapeutic terminals on a tip configured to deliver high voltage pulses safely to a patient. The electrode includes sleeves, bosses, wiring channels, and other features that maximize a minimum clearance distance (across non-conductive surfaces) and air clearance between conductive connectors themselves or the connectors and a user, thus preventing dangerous arcing. Internal surfaces and seams are taken into account. The connector and its mating outlet can include similar features to maximize clearance distance. Skirts, skirt holes, and finger stops are also employed, and they can be on either the connector or outlet, or the tip or handle of the electrode.
    Type: Grant
    Filed: September 19, 2017
    Date of Patent: February 22, 2022
    Assignee: PULSE BIOSCIENCES, INC.
    Inventors: Mark P. Kreis, David J. Danitz, Cameron D. Hinman, Sean N. Finson
  • Patent number: 11235141
    Abstract: Disclosed are systems and methods for use of an inductive link for a communication channel in a transcutaneous energy transfer system. An example system may include a resonant circuit associated with an external primary, a power transistor connected to the resonant circuit and configured to drive the resonant circuit with a first time-varying electrical signal having a frequency, and a power driver connected to the power transistor that is configured to set the frequency of the first time-varying electrical signal to a resonant frequency to enable power transfer from the external primary to an implanted secondary. The example system may further include a communication driver operatively connected to the power transistor and configured to encode the first time-varying electrical signal with a data signal by modulating an attribute of the time-varying electrical signal as electrical power is transferred from the external primary to the implanted secondary.
    Type: Grant
    Filed: September 9, 2019
    Date of Patent: February 1, 2022
    Assignee: Minnetronix, Inc.
    Inventors: Lori Lucke, Vlad Bluvshtein, James Kurkowski, William Weiss
  • Patent number: 11235161
    Abstract: Ventricle-from-atrium (VfA) cardiac therapy may utilize a tissue-piercing electrode implanted in the left ventricular myocardium of the patient's heart from the right atrium through the right atrial endocardium and central fibrous body. The exemplary devices and methods may determine whether the tissue-piercing electrode is achieving effective left ventricular capture. Additionally, one or more pacing parameters, or paced settings, may be adjusted in view of the effective left ventricular capture determination.
    Type: Grant
    Filed: September 26, 2019
    Date of Patent: February 1, 2022
    Assignee: Medtronic, Inc.
    Inventor: Subham Ghosh